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Glucose Decouples Intracellular Ca2+ Activity from
Glucagon Secretion in Mouse Pancreatic Islet Alpha-Cells
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Abstract
The mechanisms of glucagon secretion and its suppression by glucose are presently unknown. This study investigates the
relationship between intracellular calcium levels ([Ca2+]i) and hormone secretion under low and high glucose conditions. We
examined the effects of modulating ion channel activities on [Ca2+]i and hormone secretion from ex vivo mouse pancreatic
islets. Glucagon-secreting a-cells were unambiguously identified by cell specific expression of fluorescent proteins. We
found that activation of L-type voltage-gated calcium channels is critical for a-cell calcium oscillations and glucagon
secretion at low glucose levels. Calcium channel activation depends on KATP channel activity but not on tetrodotoxin-
sensitive Na+ channels. The use of glucagon secretagogues reveals a positive correlation between a-cell [Ca2+]i and
secretion at low glucose levels. Glucose elevation suppresses glucagon secretion even after treatment with secretagogues.
Importantly, this inhibition is not mediated by KATP channel activity or reduction in a-cell [Ca
2+]i. Our results demonstrate
that glucose uncouples the positive relationship between [Ca2+]i and secretory activity. We conclude that glucose
suppression of glucagon secretion is not mediated by inactivation of calcium channels, but instead, it requires a calcium-
independent inhibitory pathway.
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Introduction
Pancreatic islets respond to changes in blood glucose levels so
that glucagon secretion from a-cells is maximal under hypogly-
cemic conditions (below 4 mM), whereas insulin is secreted from
b-cells maximally at glucose levels greater than 8 mM [1,2].
The primary function of glucagon is to prevent hypoglycemia
by stimulating glucose output from the liver [3]. Once
normoglycemia is reestablished, glucagon release is suppressed.
The molecular mechanisms leading to glucagon secretion and
to its suppression by glucose are largely unknown [4]. Despite
their opposite responses to glucose, a- and b-cells contain
comparable secretory pathways: glucose transporters, the glyco-
lytic enzyme glucokinase, ATP-sensitive K+ (KATP) channels,
high-voltage-gated calcium channels, and secretory granules [4].
In b-cells, breakdown of glucose generates disposable energy
(increase in ATP to ADP ratio) that mediates the exocytosis of
insulin granules via closure of KATP channels, plasma
membrane depolarization, and calcium channel activation,
respectively [5]. A similar KATP- dependent depolarizing
pathway appears to be present in a-cells, but its role in
glucagon secretion, if any, is poorly understood. Various models
have been proposed in which glucose overcomes this depolar-
izing pathway. In one model, low glucose concentrations set the
a-cell membrane potential to a level that allows activation of
voltage-gated sodium channels, which in turn leads to calcium
channel activation and glucagon secretion. In this model,
elevated glucose concentrations activate the KATP- dependent
depolarizing pathway, which then inactivates sodium channels,
and suppresses glucagon secretion [6–8]. An alternate model
speculates that paracrine inhibitors released from b-cells (e.g.
insulin and zinc ions) suppress glucagon secretion by activation
of a-cell KATP channels, membrane hyperpolarization, and
inactivation of calcium channels [9,10]. Although both models
of glucagon suppression by glucose describe opposite effects on
a-cell membrane polarization, they both rely on calcium
channel inhibition. In contrast, we previously reported that a-
cell calcium dynamics was not suppressed by glucose [1]. In the
present study, we further investigate the relationship between a-
cell [Ca2+]i and glucagon secretion at low glucose levels, and at
inhibitory glucose concentrations. We examined the effects of
modulating various ion channel activities that previous models
have proposed to be important for a-cell function. We present a
set of results acquired using islets from C57BL/6 mouse
background performed under consistent conditions that allow
comparison between different treatments. Using this approach,
we measured the effects of glucose on [Ca2+]i and glucagon
secretion from islets stimulated by glucagon secretagogues. Our
results confirm a positive correlation between a-cell [Ca2+]i and
glucagon secretion at low glucose levels, and indicate that
greater glucose concentrations inhibit glucagon secretion inde-
pendently from a-cell [Ca2+]i levels.
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Results
Glucose Effects on Hormone Secretion from Perifused
Islets
To establish the secretory dynamics of our system, we
measured the time course of hormonal responses from perifused
intact mouse islets exposed to a step-increase in D-glucose
concentration (Fig. 1). By comparing the baseline secretion at
1 mM glucose with measurements obtained 15 to 18 minutes
after glucose elevation to 12 mM, we found that glucose sharply
reduces the rate of glucagon release by 64.8 616.4% (p,0.01).
Meanwhile, insulin secretion from b-cells is strongly stimulated
and exhibits a typical biphasic response composed of an acute
first phase that lasts ,10 minutes followed by a second phase
plateau that starts at the nadir of the first phase [11]. A step-
decrease in glucose from 12 to 1 mM restores maximal
glucagon secretion and inhibits insulin secretion (Fig. 1). The
recovery of glucagon secretion is much slower than its inhibition
by glucose, consistent with previous reports [12–14].
a-cell Responses to Modulation of High-voltage-gated
Calcium Channel Activity
a-cells only constitute ,15% of mouse islet cells [15]. As a
result, it has been challenging to rigorously identify them in intact
living islets. The transgenic expression of tdRFP in a-cells
overcomes this limitation and is well-suited for Fluo-4 calcium
imaging studies [1]. Nifedipine and v-conotoxin were used to
selectively block L- and N-type calcium channels, respectively
[16]. In Figure 2A, a representative Fluo-4 experiment shows that
v-conotoxin at 1 mM does not affect either a- or b-cell [Ca2+]i at
low glucose levels. Greater concentrations were also tested (up to
10 mM) but no response was observed. In contrast, nifedipine
(20 mM) strongly inhibits a-cell calcium oscillations. On average,
20 mM nifedipine reduces a-cell Fluo-4 signal by 18.2 63.7%
(n = 15, p,0.01). Lower concentrations of nifedipine also reduce
the amplitude of calcium oscillations (Fig. 2B). Nifedipine
inhibition of L-type calcium channels suppresses glucagon
secretion by 55.0 63.7% (p,0.01) in islets perifused at low
glucose levels (Fig. 2C). In contrast, v-conotoxin did not affect
glucagon secretion from intact islets in static incubation experi-
ments at 1 mM glucose (0.69 60.29% of total cellular glucagon
content secreted during 1 hour at 1 mM glucose, n = 5, vs. 0.62
60.25% in the presence of 1 mM v-conotoxin, n = 5; p = 0.68).
We used a maximal level of 20 mM nifedipine in our
experiments. Equal or greater concentrations of the drug have
been utilized in islets [7,17]. However, 20 mM nifedipine induces
an increase in [Ca2+]i in some b-cells exposed to low glucose levels,
whereas lower concentrations have no effect (Fig. 2A and 2B). This
effect is possibly the result of non-specific inhibition of potassium
channels by the drug that depolarizes b-cell membrane [18]. This
depolarization would also explain the transient stimulation
observed in the insulin response (Fig. 2C). This effect is unlikely
to be responsible for the glucagon response because glucagon
suppression occurs before the small rise in insulin release and
persists after its termination.
a-cell Responses to Modulation of Tetrodotoxin (TTX)-
sensitive Na+ Channels
Activation of TTX-sensitive voltage-gated Na+ channels has
been proposed to be involved in the activation of calcium channels
at low glucose levels [6–8]. However, other electrophysiological
studies failed to measure any residual sodium currents at
physiological membrane potentials in a-cells [19,20] but detected
it in a subset of b-cells [19]. We therefore tested the effect of TTX
on islets containing RFP-labeled a-cells loaded with Fluo-4. We
applied TTX at low glucose levels to determine if inhibition of
TTX-sensitive Na+ channels would inhibit a-cell [Ca2+]i oscilla-
tions. We did not observe any significant decrease in a-cell [Ca2+]i
with TTX supplemented in the range of 0.1 to 1 mg/mL (i.e 0.3 to
3 mM) (Figure 3A). Although not statistically significant, TTX
appears to induce a slight stimulatory effect on a-cells, as indicated
by an acceleration in the frequency of [Ca2+]i oscillations
(1.2360.23 oscillation per minute vs. 1.4760.29 when 1 mg/mL
of TTX is applied, p = 0.18); while having no effect on b-cell
[Ca2+]i. Islets exposed to 1 mg/mL TTX exhibit a 25.2 612.2%
(p,0.05) increase in glucagon secretion (Fig. 3B), but TTX does
not affect insulin secretion.
a-cell Responses to Modulation of KATP Channel Activity
b-cell KATP channels couple cell metabolism to electrical
activity and are therefore pivotal in triggering glucose-stimulated
insulin secretion [5]. Expression of KATP channels has been
reported in a-cells at similar or greater density compared to that in
b-cells [20,21], but their function in glucagon secretion remains
poorly understood. [Ca2+]i was monitored by Fluo-4 fluorescence,
and 100 mM diazoxide, a KATP channel activator, was perifused
over the islets. Activation of KATP channels caused a strong
reduction in the frequency and/or amplitude of calcium oscilla-
tions in 55% of oscillating a-cells (n = 20). Representative calcium
responses are presented in Figure 4A. Diazoxide had no effect on
the 20% of a-cells that were not oscillating, possibly because these
cells were already too hyperpolarized to allow the activation of
high-voltage-gated calcium channels. Overall, we found that
diazoxide treatment at low glucose levels reduced the Fluo-4
signal by 22.6 65.2% (n = 25, p,0.01) in a-cells, whereas b-cell
intensity was not affected (+9.8 69.7% in b-cells, n = 7 islets).
Lower diazoxide concentrations (20 mM) were also found to
inhibit calcium activity in 12 out of 15 oscillating a-cells (data not
shown). Furthermore, diazoxide suppresses glucagon secretion by
47.8 613.0% (p,0.01) at 1 mM glucose, but does not affect
insulin secretion (Fig. 4B). Because b-cell secretory activity is
Figure 1. Glucose effects on hormone secretion from perifused
islets. Isolated islets were exposed to 1 mM glucose for 30 minutes
(from 230 to 0 min). Then, both glucagon and insulin responses (gray
and black traces, respectively) were measured for 15 minutes at 1 mM
glucose (G1). The perifusion was changed to 12 mM (G12) for 15
minutes, and then switched back to 1 mM. Experiment was repeated 3
times, 450 islets from 6 mice were used. Error bars represent the
standard error of the mean. To compare the volume of islets with
different diameters and volumes, individual islets were mathematically
converted to standard islet equivalents (IEQs) with a diameter of
150 mm [44].
doi:10.1371/journal.pone.0047084.g001
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Figure 2. Effects of high-voltage-gated calcium channel inactivation on islet [Ca2+]i and hormone secretion. A, representative
intracellular calcium responses to blockade of N- and L-type calcium channels. Gray traces represent a-cell [Ca2+]i, and black traces indicate b-cell
[Ca2+]i. Fluo-4 intensity is expressed in arbitrary units. Calcium responses from two a-cells in the same islet are shown. N- and L-type channel
inhibitors (1 mM v-conotoxin and 20 mM nifedipine, respectively) were perifused. The figure is representative of 15 a-cells from 5 islets isolated from 3
mice. B, increasing concentrations of nifedipine were perifused at times indicated by the arrows. Nifedipine (# 10 mM) reduces calcium activity in a-
cells without affecting b-cell [Ca2+]i. The figure is representative of 10 a-cells from 3 islets harvested from 3 mice. C, effects of nifedipine on hormone
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minimal under these conditions, a-cell inhibition by diazoxide is
likely due to direct activation of a-cell KATP channels, and not to
indirect paracrine effects.
A KATP channel blocker, tolbutamide (100 mM), was then
applied to islets perifused at 1 mM glucose. We observed an
increase in calcium activity in ,45% (n = 34) of a-cells (Fig. 4C
and 4D), but the effect of tolbutamide was heterogeneous from cell
to cell. Some a-cells behave like b-cells and quickly respond by a
strong rise in [Ca2+]i, whereas others responded more slowly. We
noticed that ,25% of a-cells exhibited transient inhibition in the
frequency/amplitude of calcium oscillations for 5–10 minutes
before recovering (Fig. 4E). In addition, tolbutamide had no
significant effect on ,25% of active a-cells, possibly because KATP
channels were already closed in these cells. Finally, we observed an
inhibition of calcium activity in ,5% of the a-cells. On average,
tolbutamide increased a-cell Fluo-4 signal by 36.9 611.5%
(Fig. 4F) and glucagon secretion from islets by 62.8 626.7%
(p,0.01). Under the same conditions, the Fluo-4 signal in b-cells
increased by 140.8 625.0% (p,0.01), and insulin secretion was
also elevated. The time-response to tolbutamide indicates that
insulin release is quickly stimulated, whereas glucagon secretion is
only enhanced after ,15 minutes. This time-lag between insulin
and glucagon responses corroborates our calcium measurements
describing transient suppression of calcium activity in some a-cells
(Fig. 4E).
We next sought to determine whether glucose could retain its
inhibitory effect on a-cells that were stimulated by tolbutamide.
We measured a 44.05 611.02% (p,0.01) decrease in the rate of
glucagon secretion when 12 mM glucose was applied (Fig. 4H),
while insulin secretion was increased from 4.13 61.30 to 10.36
60.44 ng/100IEQs/min. To test whether this glucagon suppres-
sion was mediated by a reduction in a-cell [Ca2+]i, we measured
the effect of glucose on islets perifused with tolbutamide and found
no significant change in Fluo-4 signal either in a- or in b-cells (4.61
610.97%, n = 12, and 0.11 617.51%, n = 5, respectively). A
representative figure is presented in Fig. 4G.
Effects of KCl- induced Depolarization of a-cells
Fluo-4 measurements indicate that KCl application increases a-
cell [Ca2+]i in both oscillating and non-oscillating cells, as shown in
Fig. 5A. On average, Fluo-4 signal was enhanced by 76.8 623.0%
in a-cells, whereas b-cell intensity was augmented by 132.9
628.9% (p,0.01, n = 14 a-cells from 5 islets isolated from 3 mice).
Islet perifusion assays reveal that KCl stimulates glucagon
secretion by 83.9 617.1% (p,0.01). KCl also increases the
release of insulin (Fig. 5B). Application of 12 mM glucose reduces
the rate of glucagon secretion by 29.57 69.13% (p,0.01), while
stimulating insulin secretion from 2.73 60.17 to 9.23 60.43 ng/
100IEQs/min. However, glucose addition did not change Fluo-4
signal in both a- and b-cells (8.22 612.31%, n = 7, and 6.72
613.09%, n = 4, respectively).
Effects of Arginine on a-cells
The amino acid L-arginine is a potent glucagon secretagogue
[22], but its mode of action has not been fully defined. Cell
metabolism can be measured by changes in the autofluorescence
of reduced pyridine nucleotides (NADH and NADPH), collectively
referred to as NAD(P)H [23]. To determine the arginine-
dependent NAD(P)H responses, we acquired the NAD(P)H
intensities of islets at 1 mM glucose and compared them with
those collected 15 to 30 minutes after arginine stimulation, when
NAD(P)H signal has reached a plateau (data not shown). The islet
NAD(P)H response to step-increases in arginine concentration was
normalized to the minimal NADH redox state obtained with
FCCP, and to the maximal signal with sodium cyanide (Fig. 6A),
[1]. a-cells dose-dependently increase their NADH redox state
with millimolar concentrations of arginine, to an extent similar to
glucose [1]. This elevation in metabolic redox state indicates that
secretion from intact perifused islets. Islets were exposed to 1 mM glucose for 30 minutes (from230 to 0 min). Glucagon and insulin responses (gray
and black traces, respectively) were measured for 15 minutes at 1 mM glucose (G1), and 20 mM nifedipine was added to the perifusion medium for 30
minutes. Experiment was repeated 4 times, 600 islets from 8 mice were used. Error bars represent the standard error of the mean.
doi:10.1371/journal.pone.0047084.g002
Figure 3. Effects of voltage-gated sodium channel inhibition on islet [Ca2+]i and hormone secretion. Gray and black traces represent a-
and b-cells, respectively. A, representative intracellular calcium responses to tetrodotoxin (TTX) in an intact mouse islet perifused at 1 mM glucose.
Increasing concentrations of TTX were perifused at times indicated by the arrows. TTX stimulates calcium activity in a-cells while having no noticeable
effects on b-cells. Fluo-4 intensity is expressed in arbitrary units. The figure is representative of 18 a-cells analyzed from 6 islets harvested from 3 mice.
B, effects of TTX on glucagon and insulin secretion from intact perifused islets. Isolated islets were exposed to 1 mM glucose for 30 minutes (from
230 to 0 min). Glucagon and insulin responses were measured for 9 minutes at 1 mM glucose (G1), and then TTX was perifused. Experiment was
repeated 6 times, 900 islets from 12 mice were used. Error bars represent the standard error of the mean.
doi:10.1371/journal.pone.0047084.g003
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arginine could activate a KATP-dependent depolarizing pathway in
this cell-type. In contrast, arginine was weakly metabolized in b-
cells, as previously reported [24].
Arginine also dose-dependently elevates a-cell [Ca2+]i (Fig. 6B).
We measure a 52.3 615.7% increase in Fluo-4 signal in a-cells in
the presence of 10 mM arginine, compared to 22.1 65.4% in b-
cells (16 a-cells from 5 islets, p,0.01 for both cell-types). Arginine
quickly augments a-cell calcium activity (Fig. 6C), and this
elevation in a-cell [Ca2+]i translates into increased rates of
glucagon release (Fig.6D). 10 mM arginine stimulates glucagon
output by 92.0 617.1% (p,0.01), whereas it has no effect on
insulin secretion. The lack of insulin response at low glucose levels
has been reported elsewhere [25].
Arginine-stimulated glucagon secretion is inhibited by glucose
[25]. The rate of glucagon secretion was reduced by 26.4 69.8
(p,0.01) (Fig. 6D), while insulin secretion was strongly stimulated
by glucose. Besides its suppressive effect on glucagon secretion,
glucose slightly increased the arginine-stimulated a-cell Fluo-4
signal by 13.6 66.55% (p,0.05, n = 35 a-cells from 6 islets
isolated from 3 mice). At the same time, 12 mM glucose increased
b-cell Fluo-4 signal by 85.3 626.2% over than seen with arginine
and 1 mM glucose.
Discussion
The study of isolated islets with an a-cell label demonstrates
that a-cell [Ca2+]i and glucagon secretion are closely related at
low glucose levels. Inhibition of L-type voltage-gated calcium
channels underlies calcium oscillations and secretory activity at
low glucose levels (Fig. 2), supporting previous evidence
[19,26,27]. However, blocking N-type channels was ineffective
in inhibiting a-cells, contrary to some previous reports [7,17,28].
At least some of this difference may be due to species
differences. Depolarizing agents such as tolbutamide and KCl
augment both a-cell [Ca2+]i and glucagon secretion. Similarly,
arginine stimulates glucagon secretion and increases a-cell
[Ca2+]i. Since arginine is metabolized in a-cells, it likely
activates a KATP-dependent depolarizing pathway, although it
can also increase the firing of action potentials by an
electrogenic effect [8]. The rapid responses in [Ca2+]i and
glucagon secretion after arginine treatment suggest that it
predominantly stimulates secretion by a direct depolarizing
effect mediated by its positive charge. In contrast, the metabolic
responses obtained with glucose necessitate 5 to 10 minutes to
be translated into an increase in [Ca2+]i [1].
We investigated the effect of TTX-sensitive voltage-gated
sodium channels that have been proposed to set the a-cell
membrane polarity to a level allowing activation of high-voltage
gated calcium channels [6–8,28]. In our hands, neither a-cell
calcium oscillations nor glucagon secretion was inhibited by TTX
(Fig. 3). In contrast, we observed a small increase in both a-cell
calcium oscillatory activity and glucagon secretion. This may
suggest that voltage-gated Na+ channels activate voltage-gated K+
channels involved in the inactivation of calcium channels [27,29],
but these data argue against a prominent role for voltage-gated
Na+ channels in calcium channel activation and normal glucagon
secretion.
Figure 4. Effects of pharmacological modulation of KATP channels on islet [Ca
2+]i and hormone secretion. Gray and black traces
represent a- and b-cells, respectively. A, representative intracellular calcium responses to KATP channel activation by 100 mM diazoxide from an islet
perifused at 1 mM (G1). Fluo-4 intensity is expressed in arbitrary units. The figure is representative of 25 a-cells analyzed from 7 islets harvested from
3 mice. B, Effect of diazoxide on hormone secretion from intact perifused islets. Isolated islets were exposed to 1 mM glucose for 30 minutes (from -
30 to 0 min). Glucagon and insulin responses were measured for 12 minutes at 1 mM glucose, and diazoxide was perifused for 30 minutes at 100 mM.
Experiment was repeated 3 times, 450 islets from 6 mice were used. Error bars represent the standard error of the mean. C, D, and E, representative
Fluo-4 responses to KATP channel inhibition from an islet perifused at 1 mM glucose. The figure shows 3 different a-cells from the same islet exposed
to 100 mM tolbutamide, and is representative of 34 a-cells analyzed from 10 islets harvested from 3 mice. F, glucagon and insulin responses were
measured for 9 minutes at 1 mM glucose, and then tolbutamide was perifused at 100 mM. Experiment was repeated 6 times, 900 islets from 12 mice
were used. G, representative Fluo-4 responses to 100 mM tolbutamide (TTX) in an intact islet perifused at 12 mM. H, glucagon and insulin secretion
from islets perifused at 1 mM glucose and 100 mM tolbutamide for 15 minutes, then glucose concentration was increased to 12 mM. Experiment was
repeated 3 times, 450 islets from 6 mice were used.
doi:10.1371/journal.pone.0047084.g004
Figure 5. Effects of KCl on islet [Ca2+]i and hormone secretion. Gray and black traces represent a- and b-cells, respectively. A, intracellular
calcium responses from an islet perifused at 1 mM followed by addition of 20 mM KCl. 2 a-cells from the same islet are presented. Fluo-4 intensity is
expressed in arbitrary units. The figure is representative of 12 a-cells from 4 islets harvested from 3 mice. B, glucagon and insulin were measured for 9
minutes at 1 mM glucose (G1), and KCl was then perifused at 20 mM for 20 minutes, and glucose was added for 15 minutes at 12 mM (G12).
Experiment was repeated 4 times, 600 islets from 8 mice were used. Error bars represent the standard error of the mean.
doi:10.1371/journal.pone.0047084.g005
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In b-cells, glucose metabolism closes KATP channels and
therefore depolarizes membrane potential from ,260 mV to
,235 mV [30]. L-type calcium channels start to open at
membrane potential higher than 250 mV and are maximally
activated between 220 mV and +10 mV [31]. Our results
indicate that a-cell L-type calcium channels do not require the
depolarizing effect of Na+ channels to be activated. This suggests
that the a-cell membrane should be fairly depolarized at low
glucose concentrations (.250 mV), which is consistent with
previous reports [27,32]. This depolarized state likely originates
from a higher metabolic state at low glucose concentrations,
compared to b-cells (Fig. 6A, [1]), that would lead to greater ATP
concentrations in a-cells, as reported in [33]. Thus, more a-cell
KATP channels should be closed at low glucose levels, compared to
b-cells, which is consistent with the reduced effect of tolbutamide
on a-cell [Ca2+]i (Fig. 4). This hypothesis is further supported by
the fact that a-cell KATP channels are more sensitive to ATP
compared to b-cell KATP [20]. The observation that arginine and
KCl elicit greater a-cell [Ca2+]i and secretion responses than does
tolbutamide, suggests that they depolarize the a-cell membrane to
a greater extent and thus activate more calcium channels.
Interestingly, the glucagon response following arginine and KCl
application is biphasic (Fig. 5B and 6D). The acute first phase may
be the result of exocytosis of a readily releasable pool of glucagon-
containing granules, whereas the acceleration in the rate of
glucagon secretion during the second phase suggests that elevated
[Ca2+]i promotes an amplifying pathway at low glucose levels, as
seen in b-cells at greater glucose concentrations [5]. Activation of a
non- KATP-dependent amplifying pathway by glucose is observed
in b-cells when islets are exposed to KCl and tolbutamide at high
glucose levels (Fig. 4H and 5B). As a result, the rate of insulin
secretion is increased whereas b-cell [Ca2+]i is not.
The role of a-cell KATP channels in glucagon secretion is
controversial. Some studies have reported that blocking KATP
channels would lead to calcium channel inactivation [6–8]. Our
Fluo-4 imaging that assays all of the labeled a-cells reveals a subset
in which tolbutamide suppresses calcium oscillations, but this
inhibition was only transient (Fig. 4E). The different responses to
tolbutamide (and diazoxide) application illustrate the importance
of heterogeneities in the a-cell population, as some cells are in an
excited state at low glucose levels while others are quiescent [1].
Electrophysiological experiments identify active cells, and those
Figure 6. Effects of L-arginine on islet NAD(P)H, [Ca2+]i, and hormone secretion. Gray and black columns and traces represent a- and b-
cells, respectively. A, arginine-dependent NAD(P)H responses from intact islets. Islets were perifused at 1 mM glucose (G1) and exposed to step-
increases in arginine concentration. Data are normalized to minimal and maximal b-cell NAD(P)H obtained with FCCP and cyanide, respectively. The
a-cell NAD(P)H changes to arginine (Arg) were statistically significant (p,0.01, 32 a-cells measured from 10 islets, 3 mice) and a-cell NAD(P)H intensity
was different from b-cell intensity for each condition tested (p,0.01). Error bars indicate the standard error of the mean. B, averaged intracellular
calcium responses to arginine. Data are expressed in percent change in Fluo-4 intensity compared to baseline at 1 mM glucose. a-cell responses to
arginine were significant at all concentrations (p,0.01, n = 42) and b-cell responses were significant at 10 and 20 mM arginine (p,0.01, n = 11). C,
intracellular calcium responses to 10 mM arginine from an islet perifused at 1 mM glucose (G1). 2 a-cells from the same islet are presented. Fluo-4
intensity is expressed in arbitrary units. The figure is representative of 11 a-cells from 4 islets. D, glucagon and insulin responses were measured for 9
minutes at 1 mM glucose, and then arginine was perifused at 10 mM for 18 minutes. Finally, glucose was added to the perifusion medium at 12 mM
for 18 minutes. Experiment was repeated 4 times, 600 islets from 8 mice were used. Error bars represent the standard error of the mean.
doi:10.1371/journal.pone.0047084.g006
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experiments find that only 7% of the cells examined are a-cells
[17], even though .25% of the peripheral mouse islet cells should
be a-cells. Contrary to findings based on the subset of a-cells that
are active at any moment under low glucose conditions, we find
that tolbutamide elevates a-cell [Ca2+]i in a majority of a-cells and
stimulates glucagon secretion (Fig. 4). This positive effect is
consistent with other reports [10,21,26,28,34] and suggests that
KATP channels are active at low glucose levels, in contrast to some
reports in which tolbutamide had no effect [35,36]. Increased
glucagon secretion in response to tolbutamide also challenges the
paracrine model of glucagon suppression by glucose. Because b-
cells are activated by tolbutamide, insulin and zinc are released
and would be expected to inhibit glucagon secretion. Similarly,
KCl depolarizes a-cell membranes and raises a-cell [Ca2+]i, while
stimulating both glucagon and insulin secretion (Fig. 5, [37,38]). In
these cases, paracrine inhibitory products are apparently unable to
overcome the stimulatory effect of tolbutamide and KCl on
glucagon secretion, likely because they both force the a-cells into a
depolarized state. Overall, the results obtained with tolbutamide,
KCl, and arginine, indicate that membrane depolarization and
calcium channel activation account for a-cell secretory activity at
low glucose levels.
Activation of KATP channels by diazoxide increases the outward
current of K+ and hyperpolarizes the a-cell membrane. The
inhibitory effect of diazoxide on a-cell calcium activity (Fig. 4)
suggests that membrane hyperpolarization inactivates L-type
calcium channels, and thus suppresses glucagon secretion. a-cell
KATP channel activity is therefore important for setting the
membrane potential to a level that allows activation of calcium
channels under low glucose conditions. Interestingly, both
diazoxide and L-type channel blocker inhibit the secretion of
glucagon to an extent similar to glucose (Fig. 1, 2C, and 4B). It is
tempting to hypothesize that glucose mediates its inhibition by
opening KATP channels and inactivating calcium channels, as
proposed in [9,10]. However, we have previously reported that a-
cell calcium activity was not reduced by glucose [1]. We further
illustrate this uncoupling between a-cell [Ca2+]i and secretion by
showing that glucose suppresses arginine-stimulated glucagon
secretion without a decrease in a-cell [Ca2+]i (Fig. 6). Similarly,
glucose reduces the rate of glucagon secretion from islets
stimulated by KCl and tolbutamide without affecting a-cell
[Ca2+]i. In each of these cases, glucagon suppression by glucose
is concomitant with an increase in b-cell secretory activity, so it is
difficult to determine if suppression of glucagon results from direct
effect of the sugar on a-cells or by an indirect paracrine inhibition
from b-cells.
In summary, we propose that a-cell KATP channels are
important at low glucose levels to create a fairly depolarized
membrane potential that allows spontaneous activation of L-type
calcium channels and exocytosis of glucagon-containing granules.
Our results further show that KATP channels are not involved in
glucose suppression of glucagon secretion. Instead, glucose inhibits
secretion by a non-calcium-dependent pathway, which likely




Fluo4-AM, fetal bovine serum, penicillin, streptomycin, Hanks
balanced salt solution, phosphate buffer saline (PBS) and Roswell
Park Memorial Institute (RPMI) 1640 medium were purchased
from Invitrogen (Carlsbad, CA). Collagenase P was obtained from
Roche (Basel, Switzerland) and tetrodotoxin from Tocris Biosci-
ence (Ellisville, MO). Unless specified, all other products were
purchased from Sigma-Aldrich (St. Louis, MO).
Transgenic Mice and Islet Culture
All work with animals was conducted in compliance with the
Vanderbilt University Institutional Animal Care and Use Com-
mittee (IACUC). Transgenic mice (C57BL/6 genetic background)
that specifically express tandem-dimer Red Fluorescent Proteins
(tdRFP) in a-cells have been described elsewhere [1]. Transgenic
mice were identified by polymerase chain reaction (PCR) on
mouse-tail DNA (Puregene Mouse Tail Kit, Gentra Systems,
Minneapolis, MN). Oligonucleotide primers for Glucagon-Cre
mice are: 59-CCT CTA GGC TCA TTT GAC G-39 (forward)
and 59-TCC ATG GTG ATA CAA GGG AC-39 (reverse).
ROSA26-tdRFP mice are identified with ROSA26 primers, as
described in [39]. Islets were isolated and cultured as previously
described [1]. Islets were cultured overnight for the secretion
assays, and up to 3 days for imaging studies.
Live-cell Imaging
Islets were imaged in a microfluidic device placed on the
microscope stage, in a temperature controlled chamber at 37uC
and 5% CO2. The microfluidic chip holds the living islet stable for
imaging and allows rapid reagent changes. The fabrication of the
device has been described elsewhere [40,41]. Islets were studied in
imaging solution (i.e. filtered aqueous solution containing:
125 mM NaCl, 5.7 mM KCl, 2.5 mM CaCl2 – 2H2O, 1.2 mM
MgCl2, 10 mM HEPES and 0.1% bovine serum albumin, at
pH7.4). For calcium imaging, islets were incubated with 5 mM of
Fluo4-AM for one hour at 1 mM glucose. An increase in Fluo-4
intensity relates to greater [Ca2+]i and the response is a function of
physiological free calcium concentrations [42]. After washing,
islets were allowed to equilibrate on the microscope stage for 15
minutes. Fluo-4 was excited at 488 nm and its emission was
recorded between 490 and 560 nm. Time-series images were
acquired every 3 seconds. a-cells were localized thanks to the
expression of tdRFP. TdRFP was excited at 561 nm and its
fluorescence collected between 565 and 730 nm. We used a laser
scanning microscope (LSM710, Carl Zeiss Inc., Thorwood, NY)
with a Fluar 40x/1.3NA oil immersion lens (Zeiss). Confocal
sections were obtained with a pinhole diameter set to 2 Airy units.
Because b-cells constitute ,80% of the cells in the islet [15], the
Fluo-4 signal from non-tdRFP cells was considered to represent
the average b-cell response. NAD(P)H measurements by two-
photon excitation were performed as previously described [1].
Measurements of Insulin and Glucagon Secretion from
Perifused Islets
One day after isolation, islets were split into groups of 150 islets.
Each group was placed into one of the individual glass chambers of
a cell perfusion system for simultaneous study [43]. Islets were
settled in each column on top of mesh filters with 25 mm pores to
prevent islets from escaping into the effluent. Each experiment was
preceded by a 30-minute stabilization period using a perifusion of
0.1% Dulbecco’s Modified Eagle Medium (DMEM) containing
0.1% BSA, 4.66 mM HEPES, 38.1 mM NaHCO3, 1 mM sodium
pyruvate, 4 mM L-glutamine, and 0.015% phenol red, at pH7.4.
Additional glucose and/or drugs were added to the perifusion
medium as indicated in the text. A flow rate of 1 ml/min was used
and samples were collected every 3 minutes by the Vanderbilt Islet
Procurement and Analysis Core. Hormone secretion measurement
was performed in duplicate by radio-immunoassays in the
Vanderbilt Hormone Assay Core. Individual islets were mathe-
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matically converted to standard islet equivalents (IEQs) with a
diameter of 150 mm [44]. 1h-static perifusion assays with v-
conotoxin were performed as described in [1].
Data Analysis and Statistics
Image data were analyzed with Metamorph 7.6.1 (MDS
Analytical Technologies, Downingtown, PA) and Excel 2007
(Microsoft, Redmond, WA) as previously described [1]. P values
(two-tailed paired t-test) for glucagon measurements were obtained
by comparing the baseline with measurements obtained 15 to 18
minutes after reagent change. Statistical analyses were performed
by Prism 4 (GraphPad Software, La Jolla, CA).
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